Roy B. Tishler
ORCID: 0000-0002-0012-6055Also affiliated with Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck”.
Anne O'Neill, Kee-Young Shin, Kristine Wong, Vickie Y. Jo, Charles T. Quinn +20 more
Jirapat Likitlersuang, Dennis Bontempi, Zezhong Ye, Sanjay Aneja, Richard L. Bakst +16 more
Michael J. Dennis, Nicole Scarfo, Michelle S. Mullin, Rosh K.V. Sethi, Kartik Sehgal +9 more
Michael Milligan, Jonathan D. Schoenfeld, Roy B. Tishler, Andrea K. Ng, Phillip M. Devlin +8 more
Anurag Saraf, Yashwanth Ravipati, Frank Hoebers, Yining Zha, Anna Zapaishchykova +16 more
Kee‐Young Shin, Manisha Thakuria, Jonathan D. Schoenfeld, Roy B. Tishler, Ann W. Silk +4 more
Laura A. Goguen, Donald J. Annino, Roy B. Tishler, Claudia I. Chapuy, Robert I. Haddad +1 more